SEARCH RESULTS FOR:

Rodrigo Couto

PRESIDENT LATAM, HEXAGON
"We aim to be technology enablers by consolidating multiple operational solutions into a single interface."

Rodrigo Vilela

CEO, SAMARCO
"In 2025, we aim to produce approximately 15 million t of pellets, which positions us as one of the largest exporters globally, as we were in the past."

Gbenga Komolafe

COMMISSION CHIEF EXECUTIVE, NIGERIAN UPSTREAM PETROLEUM REGULATORY COMMISSION (NUPRC)
"As a 21st-century regulator, the NUPRC aims to create value transparently, ethically, and sustainably for Nigerians and stakeholders."

Edilson Bartolomeu

CEO, ACREP ANGOLAN E&P COMPANY
"We are committed to becoming a major independent energy producer. This goal drives us to explore new opportunities and monetize the existing gas reserves in the Cabinda South Block."

Martin Sack

REGIONAL HEAD AMERICAS, LESCHACO
"Latin America has the advantage of pivoting to different economies and cannot simply align exclusively with one major power over another."

Jorge García

GENERAL MANAGER, PETROQUIM
"While being local offers the advantage of swiftly managing stock shortages, the real key is staying close to the client and providing top-tier support."

Óscar Navas

BUSINESS DEVELOPMENT DIRECTOR – ANDEAN REGION, TECHINT ENGINEERING & CONSTRUCTION
"We leverage our experience in Chile, where we work on the ongoing construction of desalination plants and water pumping systems." 

Alvaro López

GENERAL MANAGER, WEIR PERU
"In mines with an established history, the challenge lies in balancing continuous improvement of efficiency and sustainability with maintaining daily operability and performance results." 

Rodrigo Nunes

COO, HOCHSCHILD MINING
"Our positive experience in Brazil has encouraged us to continue growing in the country."

Bernardo Viana

PARTNER, GE21 CONSULTORIA MINERAL
"Last year we saw significant project growth, particularly with rare earth elements."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS